The Journal of Bone and Joint Surgery (American) 86:136-140 (2004)
© 2004 The Journal of Bone and Joint Surgery, Inc.
Prevention of Deep-Vein Thrombosis After Total Knee Arthroplasty in Asian Patients
Comparison of Low-Molecular-Weight Heparin and Indomethacin
Ching-Jen Wang, MD1,
Jun-Wen Wang, MD1,
Lin-Hsiu Weng, MD1,
Chia-Chen Hsu, MD1,
Chung-Cheng Huang, MD1 and
Pao-Chu Yu, MD1
1 Departments of Orthopedic Surgery (C.-J.W., J.-W.W., L.-H.W., and C.-C. Hsu)
and Diagnostic Radiology (C.-C. Huang and P.-C.Y.), Chang Gung Memorial
Hospital, 123 Ta-Pei Road, Niao-Sung Hsiang, Kaohsiung 833, Taiwan. E-mail
address for C.-J. Wang:
w281211{at}adm.cgmh.org.tw.
Investigation performed at the Departments of Orthopedic Surgery and
Diagnostic Radiology, Chang Gung Memorial Hospital, Kaohsiung, Taiwan
The authors did not receive grants or outside funding in support of their
research or preparation of this manuscript. They did not receive payments or
other benefits or a commitment or agreement to provide such benefits from a
commercial entity. No commercial entity paid or directed, or agreed to pay or
direct, any benefits to any research fund, foundation, educational
institution, or other charitable or nonprofit organization with which the
authors are affiliated or associated.
Background: A prospective clinical study was performed to compare
the efficacy of low-molecular-weight heparin and indomethacin for the
prevention of deep-vein thrombosis after total knee arthroplasty in Asian
patients.
Methods: One hundred and fifty patients undergoing total knee
arthroplasty were randomly divided into three groups. One group consisted of
fifty-one patients who received no prophylaxis with an anticoagulant (the
control group), one consisted of fifty patients who received the
low-molecular-weight heparin Fraxiparine (the Fraxiparine group), and the
third consisted of forty-nine patients who received indomethacin (the
indomethacin group). Bilateral ascending venography was performed
preoperatively and at five, six, or seven days postoperatively. A third
venogram was made at three months for patients who had had a deep-vein
thrombosis.
Results: The prevalence of deep-vein thrombosis was 71% in the
control group, 50% in the Fraxiparine group (p = 0.042), and 45% in the
indomethacin group (p = 0.011). Only 28% of the deep-vein thromboses were
symptomatic, and there were no pulmonary emboli.
Conclusions: Compared with no prophylaxis, Fraxiparine and
indomethacin significantly lowered the prevalence of deep-vein thrombosis
after total knee arthroplasty. Prophylaxis against deep-vein thrombosis in the
Asian population appears to be warranted.
Level of Evidence: Therapeutic study, Level I-1a
(randomized controlled trial [significant difference]). See Instructions to
Authors for a complete description of levels of evidence.

CiteULike Connotea Del.icio.us Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Leizorovicz and SMART Venography Study Steering Committee
Epidemiology of post-operative venous thromboembolism in Asian patients. Results of the SMART venography study
Haematologica,
September 1, 2007;
92(9):
1194 - 1200.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|